Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.53 | €3.70 | 141.672% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.40 | €24.13 | 56.760% |
Drägerwerk AG & Co. KGaA ST | 2 | 0 | 0 | 0 | €47.10 | - | - |
Medtronic plc | 9 | 1 | 0 | 0 | €78.38 | €93.46 | 19.234% |
EssilorLuxottica SA | 3 | 0 | 0 | 0 | €210.10 | €204.50 | -2.665% |
Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
Fresenius Medical Care AG & Co KGaA ST | 4 | 0 | 0 | 0 | €39.73 | €50.00 | 25.849% |
Olympus Corp. | 1 | 0 | 0 | 0 | €15.02 | - | - |
Trinity Biotech ADR | 23 | 0 | 1 | 0 | €0.41 | - | - |
Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.86 | €4.00 | 39.860% |
Verastem Inc. | 10 | 0 | 1 | 0 | €11.00 | €24.63 | 123.953% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.87 | €4.16 | 122.524% |
Abbott Laboratories | 16 | 0 | 1 | 0 | €94.51 | €116.81 | 23.593% |
UCB S.A. | 2 | 0 | 0 | 0 | €128.25 | - | - |
Cigna Corp. | 17 | 0 | 2 | 0 | €310.25 | €342.35 | 10.347% |
Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | €403.25 | €416.05 | 3.174% |
Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.26 | €35.99 | 32.008% |
Myriad Genetics | 6 | 2 | 1 | 0 | €23.00 | €24.18 | 5.134% |
Novavax Inc. | 5 | 3 | 3 | 2 | €13.48 | €9.80 | -27.307% |
US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €97.00 | €109.94 | 13.344% |
Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.51 | €26.95 | 156.420% |
Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €83.30 | €88.17 | 5.846% |
GSK plc | 1 | 0 | 0 | 0 | €20.48 | - | - |